How to talk to your kids about school violence

A psychologist offers advice for parents on how to talk to children about school violence and safety

From: http://www.cbsnews.com/news/talking-to-children-about-school-violence/

Coffee May Have Bigger Effect on You Than Thought

The possible benefits include lower risks of Parkinson's disease, diabetes, multiple sclerosis and certain cancers.

From: https://www.webmd.com/diet/news/20180315/coffee-may-have-bigger-effect-on-you-than-thought?src=RSS_PUBLIC

Dirty Air May Harm Blacks More Than Whites

Researchers found that blacks living in areas where this type of pollution is high have a 45 percent higher risk of heart disease and death from any cause than whites, even after taking into account other common risk factors.

From: https://www.webmd.com/lung/copd/news/20180315/dirty-air-may-harm-blacks-more-than-whites?src=RSS_PUBLIC

FDA Considers Lowering Nicotine Levels in Cigarettes

Tobacco use -- mainly cigarette smoking -- kills more than 480,000 Americans a year and costs nearly $300 billion a year in direct health care and lost productivity, the FDA noted.

From: https://www.webmd.com/smoking-cessation/news/20180315/fda-considers-lower-nicotine-levels-in-cigarettes?src=RSS_PUBLIC

FDA begins push to drastically cut nicotine in cigarettes

The FDA says under its sweeping anti-smoking plan, about 5 million more people would quit cigarettes within a year of new nicotine limits

From: http://www.cbsnews.com/news/fda-begins-push-to-drastically-cut-nicotine-in-cigarettes/

Female fertility animation

From: Mayo Clinic https://www.youtube.com/watch?v=SiNHMWkJYs0

OMS : Respire la vie – la pollution de l’air affecte notre santé

From: World Health Organization https://www.youtube.com/watch?v=Uc1HvjxMEeo

Mayo Clinic Minute: Restless legs syndrome in kids

From: Mayo Clinic https://www.youtube.com/watch?v=-3rUXrYk9Sg

Kids can open child-resistant pill bottles in seconds

Every 12 days, a child dies from medicine-related poisoning, according to a new report from Safe Kids Worldwide

From: http://www.cbsnews.com/news/too-many-children-die-accidental-medicine-poisoning-safe-kids-worldwide-report/

Does your bottled water contain plastic?

What researchers found in 11 common brands is disturbing, but health implications are far from clear

From: http://www.cbsnews.com/news/plastic-particles-in-bottled-water-suny-research-orb-media-2018-03-15/

How to talk to your kids about school violence

Many parents struggle with what to tell their children about rare but frightening instances of school violence. CBS News' Meg Oliver gets some advice on how to handle the conversation from psychologist Lisa Damour.

From: http://www.cbsnews.com/video/how-to-talk-to-your-kids-about-school-violence/

What is the importance of tumor-based genetic testing for patients with colorectal cancer?

From: Mayo Clinic https://www.youtube.com/watch?v=jPLUAe7__bY

Is there any role for liquid biopsies in the treatment of colorectal cancer? - Dr. Pashtoon Kasi

From: Mayo Clinic https://www.youtube.com/watch?v=guO8TYjns3w

Clinical Research for Colorectal Cancer at Mayo Clinic - Dr. Pashtoon Kasi

From: Mayo Clinic https://www.youtube.com/watch?v=iVKrtaYLTJI

What is the role of pharmacogenomics in the treatment of colorectal cancer? - Dr. Pashtoon Kasi

From: Mayo Clinic https://www.youtube.com/watch?v=Gf1EcrzOOrU

The rising incidence of young people with colorectal cancer - Dr. Pashtoon Kasi

From: Mayo Clinic https://www.youtube.com/watch?v=e35FSiQtuLQ

FDA approves new drug for men at high risk of prostate cancer spread

A newly approved drug called apalutamide is giving hope to thousands of men confronting a tenacious problem after being treated for prostate cancer. Prostate-specific antigen (PSA) levels should plummet to zero after surgery, and to near zero after radiation therapy, but in some men, they continue rising even when there’s no other evidence of cancer in the body. Doctors typically respond to spiking PSA with drugs that block the production of testosterone, which is the male sex hormone that fuels prostate cancer. However, this type of medically induced castration, called hormonal therapy, doesn’t always reduce PSA. Moreover, prostate cancer cells can become resistant to hormonal therapy, after which PSA resumes its upward march. This is called non-metastatic castration resistant prostate cancer (nmCRPC), and it often precedes the appearance of metastatic tumors that show up later.

The dearth of approved treatments for nmCRPC has long frustrated patients and their doctors alike. But in February, the US Food and Drug Administration approved apalutamide for men who have nmCRPC after results from the SPARTAN clinical trial showed the drug could delay metastases by up to two years. “Based on these clinical trial results, apalutamide should be considered the new standard of care for nmCRPC,” said Dr. Matthew Smith, a medical oncologist at Massachusetts General Hospital who led the study. “The drug addresses a great clinical need and holds the promise of longer survival for men whose cancer defies hormonal therapy.”

The SPARTAN trial enrolled 1,207 men whose PSA levels doubled within 10 months or less after initial treatment despite ongoing hormonal therapy. Enrolled men were assigned to either daily apalutamide tablets combined with hormonal therapy, or to hormonal therapy combined with placebo. Doctors usually stick with hormonal therapy even after PSA levels rise, since it prevents the body from recovering its ability to make testosterone. Men continued on the study until the first metastases were detected, and then they were given other drugs used for treating metastatic prostate cancer.

According to the results, those taking apalutamide avoided metastases for a median of 40.5 months (meaning half were free of metastases for longer than that, and the other half for less). The placebo-treated men, meanwhile, remained free of metastases for a median of 16.2 months, about two years less. Furthermore, apalutamide treatment “delayed symptomatic progression, pain, and other symptoms that patients experience as a consequence of their cancer,” Smith said. But apalutamide, which prevents testosterone from interacting with its receptor on cancer cells, was also associated with more frequent significant side effects, such as fatigue, rash, weight loss, falls, and skeletal fractures.

Based on accumulating evidence, Smith anticipates that longer freedom from metastases equates with longer overall survival in men with nmCRPC. However, whether that’s true remains to be seen. “So far, outcomes suggest men will live longer on apalutamide,” said Dr. Marc Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor in chief of HarvardProstateKnowledge.org. “The anxiety most patients experience when PSA increases after what was thought to be curative is significant. Continuing with this new therapy should be considered between appropriately selected patients and their doctors after a full discussion of the potential benefits and risks.”

The post FDA approves new drug for men at high risk of prostate cancer spread appeared first on Harvard Health Blog.

From: Charlie Schmidt https://www.health.harvard.edu/blog/fda-approves-new-drug-for-men-at-high-risk-of-prostate-cancer-spread-2018031513409

More Kids, Fewer Teeth for Moms?

Mothers of three had an average of four fewer teeth than moms with just two children, according to the team of European research

From: https://www.webmd.com/oral-health/news/20180315/more-kids-fewer-teeth-for-moms?src=RSS_PUBLIC

Hearing Loss Joins Long List of Smoking Harms

After accounting for work-related noise exposure and other hearing loss risk factors, the investigators found that  smokers were 1.2 to 1.6 times more likely to suffer hearing loss than people who never smoked.

From: https://www.webmd.com/smoking-cessation/news/20180315/hearing-loss-joins-long-list-of-smoking-harms?src=RSS_PUBLIC

Physical fitness tied to lower risk for dementia, study shows

New evidence suggests keeping your body physically fit can also keep you mentally fit. The new study published in the journal, Neurology, shows women who were very fit at age 50 were 88 percent less likely to develop dementia later in life. Dr. Tara Narula joins "CBS This Morning" to discuss the details of the study.

From: http://www.cbsnews.com/video/physical-fitness-tied-to-lower-risk-for-dementia-study-shows/

Child-proof medication bottles under scrutiny after accidental ingestions

A new report shows an alarming number of children are taken to the hospital for accidental poisoning by medicines. About 57,000 children under the age of six visit the emergency room each year for accidental consumption of prescription pills, over-the-counter medicine or even vitamins. Anna Werner reports.

From: http://www.cbsnews.com/video/child-proof-medication-bottles-under-scrutiny-after-accidental-ingestions/

What are the treatment options for colorectal cancer? - Dr. Tanios Bekaii-Saab

From: Mayo Clinic https://www.youtube.com/watch?v=RaRQV2fGBOE

Birth Defects Affect 7% of Zika-Exposed Babies

About 7 percent of Zika-infected women in French territories of the Caribbean delivered babies that suffered from birth defects of the brain and eyes, researchers report.

From: https://www.webmd.com/a-to-z-guides/news/20180314/birth-defects-affect-7-of-zika-exposed-babies?src=RSS_PUBLIC

Fit Middle-Aged Women May Fend Off Dementia Later

New research finds that being physically fit around age 50 lowers a woman's risk of developing memory-robbing dementia by almost 90 percent.

From: https://www.webmd.com/fitness-exercise/news/20180314/fit-middle-aged-women-may-fend-off-dementia-later?src=RSS_PUBLIC